Clinical Tools
12 reference tools extracted from the ADHD series — dosing tables, decision trees, comparison charts, and templates ready for clinical use.
Assessment
2Differential Diagnosis Decision Tree
Structured walkthrough: medical rule-outs, psychiatric differentials (anxiety, mood, trauma, ASD, SUD), and the distinguishing features of each.
→Rating Scale Comparison
Vanderbilt, Conners, SNAP-IV, BRIEF, WFIRS, and adult scales compared — what each measures, who completes it, and when to use it.
→Pharmacotherapy
3Non-Stimulant Comparison Table
Atomoxetine, guanfacine ER, clonidine ER, and viloxazine compared — mechanisms, dosing, onset timelines, and evidence summaries.
→Side Effect Management Guide
Practical strategies for appetite suppression, sleep disruption, rebound, tics, cardiovascular monitoring, and growth concerns.
→Stimulant Dosing Comparison
Side-by-side dosing for all MPH and AMP formulations — starting doses, titration steps, max doses, and age-specific first-line recommendations.
→Treatment Planning
3Age-Stratified Treatment Algorithm
Step-by-step treatment pathways for preschoolers, school-age children, adolescents, and adults — what to try first, when to switch, when to augment.
→Comorbidity Treatment Sequencing Guide
Which condition to treat first when ADHD co-occurs with anxiety, depression, ODD, tics, ASD, sleep disorders, or substance use.
→Evidence-Based Intervention Table
Effect sizes, NNTs, and evidence tiers for BPT, classroom interventions, CBT, organizational skills training, social skills, and more.
→Clinical Workflow
2IEP/504 Letter of Medical Necessity
Template letter for requesting school accommodations — structured to address eligibility criteria, functional impact, and specific recommendations.
→Monitoring Visit Checklist
What to cover at every follow-up: symptom review, side effects, vitals, growth, school functioning, adherence, and treatment response metrics.
→Patient Education
2Digital Therapeutics Evidence Summary
EndeavorRx, Akili, and emerging digital interventions — what the evidence actually shows, FDA status, and where they fit in treatment.
→Myth vs. Fact Quick Reference
Evidence-based responses to the most common misconceptions patients and families bring — screens, sugar, overdiagnosis, medication safety, and more.
→